YU41692B - Process for obtaining spiroquidyl hydantion - Google Patents

Process for obtaining spiroquidyl hydantion

Info

Publication number
YU41692B
YU41692B YU131/80A YU13180A YU41692B YU 41692 B YU41692 B YU 41692B YU 131/80 A YU131/80 A YU 131/80A YU 13180 A YU13180 A YU 13180A YU 41692 B YU41692 B YU 41692B
Authority
YU
Yugoslavia
Prior art keywords
spiroquidyl
hydantion
obtaining
spiroquidyl hydantion
obtaining spiroquidyl
Prior art date
Application number
YU131/80A
Other languages
English (en)
Other versions
YU13180A (en
Inventor
R C Schnur
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of YU13180A publication Critical patent/YU13180A/xx
Publication of YU41692B publication Critical patent/YU41692B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/12Ophthalmic agents for cataracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/24Oxygen atoms attached in position 8
    • C07D215/26Alcohols; Ethers thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/20Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/20Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Ophthalmology & Optometry (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
YU131/80A 1979-01-22 1980-01-18 Process for obtaining spiroquidyl hydantion YU41692B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/005,278 US4176185A (en) 1979-01-22 1979-01-22 Spiro-quinolylhydantoins

Publications (2)

Publication Number Publication Date
YU13180A YU13180A (en) 1983-01-21
YU41692B true YU41692B (en) 1987-12-31

Family

ID=21715098

Family Applications (1)

Application Number Title Priority Date Filing Date
YU131/80A YU41692B (en) 1979-01-22 1980-01-18 Process for obtaining spiroquidyl hydantion

Country Status (22)

Country Link
US (1) US4176185A (pt)
EP (1) EP0014079B1 (pt)
JP (1) JPS5840959B2 (pt)
KR (1) KR830001940A (pt)
AR (1) AR222685A1 (pt)
AT (1) AT365588B (pt)
AU (1) AU514271B2 (pt)
CA (1) CA1140928A (pt)
DE (1) DE3060079D1 (pt)
DK (1) DK156399C (pt)
EG (1) EG15085A (pt)
ES (1) ES487923A0 (pt)
FI (1) FI69308C (pt)
GR (1) GR72408B (pt)
IE (1) IE49365B1 (pt)
IL (1) IL59177A (pt)
NO (1) NO152172C (pt)
NZ (1) NZ192650A (pt)
PH (1) PH15472A (pt)
PT (1) PT70716A (pt)
YU (1) YU41692B (pt)
ZA (1) ZA80344B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4176185A (en) * 1979-01-22 1979-11-27 Pfizer Inc. Spiro-quinolylhydantoins
AU532110B2 (en) * 1979-11-13 1983-09-15 Ici Ltd. Spiro(imidazolidine-4,3:-indoline)-2,2:5-trione derivatives
US4248882A (en) * 1980-02-12 1981-02-03 Pfizer Inc. Treating diabetes-associated complications with hydantoin amines
JPS5745185A (en) * 1980-07-21 1982-03-13 Eisai Co Ltd Hydantoin derivative and its preparation
ATE10940T1 (de) * 1981-05-12 1985-01-15 Imperial Chemical Industries Plc Pyrrolderivate.
WO1989001775A1 (en) * 1987-09-04 1989-03-09 Pfizer Inc. Azolidinedione derivatives
US5068333A (en) * 1990-03-07 1991-11-26 Pfizer Inc. 6-chloro-3,4-dihydro-pyrano [2,3-b]pyridines having the R configuration

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1135915B (de) * 1961-06-29 1962-09-06 Asta Werke Ag Chem Fab Verfahren zur Herstellung neuer, antikonvulsiv wirksamer Spirohydantoine
US3876659A (en) * 1970-09-18 1975-04-08 Sandoz Ag Spiro tricyclic isoindolines
US4117230A (en) * 1976-10-18 1978-09-26 Pfizer Inc. Hydantoin derivatives as therapeutic agents
US4176185A (en) * 1979-01-22 1979-11-27 Pfizer Inc. Spiro-quinolylhydantoins

Also Published As

Publication number Publication date
JPS5840959B2 (ja) 1983-09-08
NZ192650A (en) 1984-04-27
AU5476680A (en) 1980-07-31
NO152172B (no) 1985-05-06
EG15085A (en) 1986-12-30
IE49365B1 (en) 1985-09-18
DK156399B (da) 1989-08-14
FI69308B (fi) 1985-09-30
US4176185A (en) 1979-11-27
ES8103090A1 (es) 1981-02-16
NO794318L (no) 1980-07-23
GR72408B (pt) 1983-11-02
PH15472A (en) 1983-01-24
KR830001940A (ko) 1983-05-19
JPS55108873A (en) 1980-08-21
IL59177A (en) 1982-11-30
ATA26780A (de) 1981-06-15
YU13180A (en) 1983-01-21
PT70716A (en) 1980-02-01
ZA80344B (en) 1981-02-25
FI800163A (fi) 1980-07-23
AU514271B2 (en) 1981-01-29
DK156399C (da) 1990-01-08
AT365588B (de) 1982-01-25
IL59177A0 (en) 1980-05-30
DK24280A (da) 1980-07-23
AR222685A1 (es) 1981-06-15
EP0014079B1 (en) 1981-11-18
IE800109L (en) 1980-07-22
EP0014079A1 (en) 1980-08-06
NO152172C (no) 1985-08-14
ES487923A0 (es) 1981-02-16
FI69308C (fi) 1986-01-10
CA1140928A (en) 1983-02-08
DE3060079D1 (en) 1982-01-21

Similar Documents

Publication Publication Date Title
YU11380A (en) Process for obtaining n-benzyl-imidazole
YU65680A (en) Process for obtaining 9-amino-alkylfluorene
PT71581A (en) Process for preparing methylene-cycloamines
YU177880A (en) Process for obtaining acyl-carbamides
YU116380A (en) Process for obtaining thiazolylidene-oxo-propionitrile
DE3061037D1 (en) Process for preparing dimethylaminosilanes
YU43305B (en) Process for obtaining 2-amino-3-benzoyl-phenylacetamides
YU41692B (en) Process for obtaining spiroquidyl hydantion
DE3060089D1 (en) Process for preparing 1-amino-2-phenoxy-4-hydroxy-anthraquinone
YU43534B (en) Process for obtaining pure chlorocyan
YU108580A (en) Process for obtaining alkoxyalkylidene hydrazinopyridazine
GB2052495B (en) Process for making hexafluorotriallylisocyanurate
YU44734B (en) Process for obtaining 3-halogen-cephalosporin iminohalogenids
YU259680A (en) Process for obtaining acylcarbamides
GB2058068B (en) Process for preparing 5-chloro-2-nitrophenol
YU63980A (en) Process for obtaining n-sulfinyl-carbamates
DE3060850D1 (en) Process for preparing naphthalenesulphochloride
YU276480A (en) Process for obtaining omega-lactams
GB2055827B (en) Process for preparing chlorothiolformates
YU90680A (en) Process for obtaining hydroxyimino-substituted aminoacetonitriles
YU310680A (en) Process for obtaining vanadyl-hydrate
YU43221B (en) Process for obtaining imidazobenzodiazepine
YU114983A (en) Process for making hydrocyanide
DE3063194D1 (en) Process for preparing cyclopentenolones
YU297780A (en) Process for obtaining glucoso-isomerase